| Entry |
|
| Name |
Chenodeoxycholic acid (JP16/INN);
Chenodiol (USAN);
Chenix (TN)
|
| Product |
|
| Generic |
|
| Formula |
C24H40O4
|
| Exact mass |
392.2927
|
| Mol weight |
392.572
|
| Structure |

     |
| Activity |
Anticholelithogenic
|
| Remark |
Same as: Therapeutic category: ATC code: |
| Target |
farnesoid X receptor (FXR) activator [HSA: 9971] [KO: K08537] |
| Pathway |
|
| Interaction |
|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
23 Digestive organ agents
236 Cholagogues
2362 Bile acids
D00163 Chenodeoxycholic acid (JP16/INN); Chenodiol (USAN)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A05 BILE AND LIVER THERAPY
A05A BILE THERAPY
A05AA Bile acid preparations
A05AA01 Chenodeoxycholic acid
D00163 Chenodeoxycholic acid (JP16/INN); Chenodiol (USAN)
 |
| Other DBs |
CAS: 474-25-9 PubChem: PDB-CCD: LigandBox: NIKKAJI: |
| KCF data |
 ATOM 28
1 C1y C 21.6230 -16.1922
2 C1y C 20.4289 -16.8853
3 C1z C 21.6289 -14.8060
4 C1x C 24.0169 -16.1980
5 C1y C 19.2409 -16.2039
6 C1y C 20.4406 -18.2658
7 C1y C 22.8286 -14.1187
8 C1x C 20.4232 -14.1245
9 C1a C 21.6230 -13.4548
10 C1x C 24.0285 -14.8118
11 C1z C 18.0759 -16.9145
12 C1x C 19.2292 -14.8234
13 C1x C 19.2466 -18.9414
14 O1a O 21.6346 -18.9588
15 C1c C 22.8345 -12.7675
16 C1y C 18.0526 -18.2598
17 C1x C 16.8702 -16.2213
18 C1a C 18.0468 -15.5457
19 C1b C 24.0052 -12.0918
20 C1a C 21.6696 -12.0859
21 C1x C 16.8702 -18.9471
22 C1x C 15.7054 -16.8969
23 C1b C 25.1700 -12.7732
24 C1y C 15.7054 -18.2598
25 C6a C 26.3407 -12.1092
26 O1a O 14.4939 -18.9530
27 O6a O 27.5057 -12.7849
28 O6a O 26.3407 -10.7580
BOND 31
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 1
8 3 9 1 #Up
9 4 10 1
10 5 11 1
11 5 12 1
12 6 13 1
13 6 14 1 #Down
14 7 15 1
15 11 16 1
16 11 17 1
17 11 18 1 #Up
18 15 19 1
19 15 20 1 #Down
20 16 21 1
21 17 22 1
22 19 23 1
23 21 24 1
24 23 25 1
25 24 26 1 #Down
26 25 27 1
27 25 28 2
28 7 10 1
29 8 12 1
30 13 16 1
31 22 24 1
|